To the Editor:
Stevenson et al. recently reported the first study on the prevalence of infertility using the Sickle Cell Disease (SCD) Implementation Consortium (SCDIC) registry, showing 16.9% of males and 23% of females with SCD reported infertility,1 in contrast to 12% of males and 11% of females in the general population.2 We commend the authors for embarking on this important work, given the increasing need to address potential infertility in SCD.3–5 However, the study’s methodological limitations suggest the prevalence of infertility in people with SCD remains uncertain.
First, population infertility rates are most accurately assessed among those who have attempted biological parenthood. Recent research examining US population-level infertility rates only included those who reported attempting pregnancy, resulting in substantive narrowing of the sample (from 10,251 to 2626 women6 and from 4928 to 157 men7), but the ability to more accurately assess infertility. In contrast, Stevenson et al. included the 2108 individuals (1224 females, 884 males) who completed infertility-specific questions in their prevalence calculation but did not report if these participants attempted pregnancy. They also did not integrate the published pregnancy data from females in the SCDIC registry into their fertile/infertile classification.1,8
Second, sample characteristics (77% unmarried; 55% aged 18– 29 years) suggest some participants classified as “fertile” may not have attempted to conceive and may not have known if their fertility was impaired (which could underestimate infertility in the sample). For instance, 15%–33% of adolescents and young adults with SCD report they do not desire biological parenthood9–11 and may not attempt it, at least not in early adulthood. Also, in the most recent National Inpatient Sample, the average age of pregnancy in women with SCD pregnancy was 27 years and did not differ from unaffected Black women.12 While the average age of first paternity in SCD is not established, paternity appears to be low in a recent publication.13 Finally, Stevenson et al. cite a single, population-based infertility study (1982–2010) to provide relative context of the problem,9 whereas more contemporary data show that infertility rates among married/cohabiting women in the general population may be only 5%–8%.10
To conclude, we commend Stevenson et al. for this hypothesis generating work and agree “a fuller understanding of infertility and SCD in the United States may contribute to more patient-centered, robust fertility care for persons with SCD who seek genetic parenthood.”1 With this goal, the infertility rates reported in this study should be interpreted cautiously, as the methodological limitations may misrepresent the problem. Rigorous population-based SCD studies are needed to: (i) determine infertility rates, (ii) inform guidelines for infertility risk and fertility preservation counseling, and (iii) characterize the infrastructure needed to deliver comprehensive, accessible reproductive health care. Finally, as people with SCD have diverse disease phenotypes and sex- and treatment-specific infertility risks, precision medicine approaches may be useful to inform individual infertility risk for this underserved and understudied population.
Footnotes
Conflicts of interest: The authors have no conflicts of interest to disclose.
References
- 1.Stevenson E, Tanabe P, Knisely M, et al. Infertility and treatment- seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry. Pediatr Blood Cancer. 2023;70:e30356. 10.1002/pbc.30356 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Chandra A, Copen CE, Stephen EH. Infertility and impaired fecundity in the United States, 1982–2010: data from the National Survey of Family Growth. Natl Health Stat Report. 2013;(67):1–18. [PubMed] [Google Scholar]
- 3.Pecker LH, Oteng-Ntim E, Nero A, et al. Expecting more: the case for incorporating fertility services into comprehensive sickle cell dis- ease care. Lancet Haematol. 2023;10(3):e225–e234. 10.1016/S2352-3026(22)00353-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Meacham LR, Pecker LH, Gee B, Mishkin A. Incorporating gonadal health counseling into pediatric care of sickle cell patients. Hematology Am Soc Hematol Educ Program. 2022;2022(1):442–449. doi: 10.1182/hematology.2022000382 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Nahata L, Quinn GP, Strouse JJ, Creary SE. Addressing fertility in adolescent boys with sickle cell disease: emerging clinical and ethical dilemmas. Blood Adv. 2023:bloodadvances.2023010292. 10.1182/bloodadvances.2023010292 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Anyalechi GE, Hong J, Kreisel K, et al. Self-reported infertility and associated pelvic inflammatory disease among women of reproductive age - National Health and Nutrition Examination Survey, United States, 2013–2016. Sex Transm Dis. 2019;46(7): 446–451. 10.1097/OLQ.0000000000000996 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Louis JF, Thoma ME, Sørensen DN, et al. The prevalence of couple infertility in the United States from a male perspective: evidence from a nationally representative sample. Andrology. 2013;1(5):741–748. 10.1111/j.2047-2927.2013.00110.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kroner BL, Hankins JS, Pugh N, et al. Pregnancy outcomes with hydroxyurea use in women with sickle cell disease. Am J Hematol. 2022;97(5):603–612. 10.1002/ajh.26495 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Radauer-Plank AC, Diesch-Furlanetto T, Schneider M, et al. Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies. Pediatr Blood Cancer. 2023;70:e30359. 10.1002/pbc.30359 [DOI] [PubMed] [Google Scholar]
- 10.Nahata L, Caltabellotta NM, Ball K, O’Brien SH, Creary SE. Desire for parenthood and reproductive health knowledge in adolescents and young adults with sickle cell disease and their caregivers. Pediatr Blood Cancer. 2018;65(2):e26829. 10.1002/pbc.26829 [DOI] [PubMed] [Google Scholar]
- 11.Nahata L, Stanek CJ, Theroux CI, Olsavsky AL, Quinn GP, Creary SE. Fertility testing knowledge and attitudes in male adolescents and young adults with SCD and their caregivers: a pilot study. Blood Adv. 2022;6(12):3703–3706. 10.1182/bloodadvances.2022007004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Early ML, Eke AC, Gemmill A, Lanzkron S, Pecker LH. Severe maternal morbidity and mortality in sickle cell disease in the National Inpatient Sample, 2012–2018. JAMA Netw Open. 2023;6(2):e2254552. 10.1001/jamanetworkopen.2022.54552 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.de Montalembert M, Voskaridou E, Oevermann L, et al. Real-life experience with hydroxyurea in patients with sickle cell disease: results from the prospective ESCORT-HU cohort study. Am J Hematol. 2021;96(10):1223–1231. 10.1002/ajh.26286 [DOI] [PubMed] [Google Scholar]
